Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Brognard

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
IUBMB Life|December 15, 2018
Orange is the new black: Kinases are the new master regulators of tumor suppressionElvira An, John Brognard
Current Opinion in Genetics & Development|December 3, 2010
Protein kinase signaling networks in cancerJohn Brognard, Tony Hunter
International Journal of Molecular Sciences|April 3, 2021
New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver KinasesRyan Bensen, John Brognard
Molecular Pharmacology|February 4, 2022
Degraders: The Ultimate Weapon Against Amplified Driver Kinases in CancerPedro Torres-Ayuso, John Brognard
Expert Opinion on Therapeutic Targets|April 30, 2025
Defeating kinases that promote tumorigenesis through non-catalytic functions with PROTACs - PIM kinase as an examplePedro Torres-Ayuso, John Brognard
Trends in Pharmacological Sciences|March 12, 2017
Reversing the Paradigm: Protein Kinase C as a Tumor SuppressorAlexandra C Newton, John Brognard
Trends in Endocrinology and Metabolism: TEM|May 31, 2008
PHLiPPing the switch on Akt and protein kinase C signalingJohn Brognard, Alexandra C Newton
Cancers|December 11, 2019
Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic TargetsPedro Torres-Ayuso, John Brognard
Cancer Discovery|October 4, 2018
Shipping Out MEK Inhibitor Resistance with SHP2 InhibitorsPedro Torres-Ayuso, John Brognard
The Journal of Biological Chemistry|December 29, 2007
The phosphatase PHLPP controls the cellular levels of protein kinase CTianyan Gao, John Brognard, Alexandra C Newton
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
IUBMB Life|December 15, 2018
Orange is the new black: Kinases are the new master regulators of tumor suppressionElvira An, John Brognard
Current Opinion in Genetics & Development|December 3, 2010
Protein kinase signaling networks in cancerJohn Brognard, Tony Hunter
International Journal of Molecular Sciences|April 3, 2021
New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver KinasesRyan Bensen, John Brognard
Molecular Pharmacology|February 4, 2022
Degraders: The Ultimate Weapon Against Amplified Driver Kinases in CancerPedro Torres-Ayuso, John Brognard
Expert Opinion on Therapeutic Targets|April 30, 2025
Defeating kinases that promote tumorigenesis through non-catalytic functions with PROTACs - PIM kinase as an examplePedro Torres-Ayuso, John Brognard
Trends in Pharmacological Sciences|March 12, 2017
Reversing the Paradigm: Protein Kinase C as a Tumor SuppressorAlexandra C Newton, John Brognard
Trends in Endocrinology and Metabolism: TEM|May 31, 2008
PHLiPPing the switch on Akt and protein kinase C signalingJohn Brognard, Alexandra C Newton
Cancers|December 11, 2019
Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic TargetsPedro Torres-Ayuso, John Brognard
Cancer Discovery|October 4, 2018
Shipping Out MEK Inhibitor Resistance with SHP2 InhibitorsPedro Torres-Ayuso, John Brognard
The Journal of Biological Chemistry|December 29, 2007
The phosphatase PHLPP controls the cellular levels of protein kinase CTianyan Gao, John Brognard, Alexandra C Newton
Pageof 6